http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-979131-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ff1377f2c7b7a059516979b8d8d5c55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-48
filingDate 1959-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d71038aef250f9613fc16561935fa06d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34bd06e941733a3a799c656d905d1479
publicationDate 1965-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-979131-A
titleOfInvention Improvements relating to cyclic sulphone compounds
abstract The invention comprises 3 hydrazino-1, 1-dioxo-tetrahydrothiophenes of the general formula <FORM:0979131/C1/1> and salts and hydrazides thereof, wherein R1, R2 and R3 are the same or different and may be hydrogen, alkyl, aryl, aralkyl, alkaryl, or sulpholane, the sulpholane ring being optionally further substituted for example by alkyl, aryl, hydroxy or hydrazino group. The invention includes such compounds as 3 hydrazino-1, 1-dioxo tetrahydrothiophene, 3 (2121-dimethylhydrazino)-1, 1-dioxotetrahydrothiophene, 2, 4-dimethyl-3-hydrazino-1, 1-dioxotetrahydrothiophene, 3 methyl-3 hydrazino-1, 1-dioxotetrahydrothiophene, NN1-di-3-sulphanyl-hydrazine, N-methyl-N-3-sulphanyl hydrazine, N-phenyl N1-3-sulphanyl hydrazine, 4-hydrazino-sulpholan-3-ol and 3, 4-dihydrazino sulpholane, and salts and hydrazides thereof. The hydrazino compounds are prepared by (1) reacting the hydrazine NHR1NR2R3 in which R1, R2 and R3 are hydrogen, alkyl, aryl or sulpholane, with an unsaturated cyclic sulphone <FORM:0979131/C1/2> which may be further substituted as above, with or without a small quantity of a strong base preferably at a temperature above 50 DEG C. and in the presence of excess hydrazine, (2) reacting the above unsaturated cyclic sulphone with a primary amine and subjecting the product to treatment with nitrous acid and then a reducing agent, (3) reacting a 3-halogeno sulpholane with a hydrazine containing at least one free hydrogen atom, (4) reacting a sulpholanylamine having at least one N-H with chloramine or an alkyl or aryl derivative thereof, and (5) reacting a 3, 4 epoxysulpholane with hydrazine and recovering the 4-hydrazino sulpholan-3-ol. Examples are given in which the above mentioned compounds are prepared by one or other of methods 1, 2, 3 and 5. Also mentioned are the formation of the nitrate, sulphate and oxalate of 3 hydrazino-3-methyl sulpholane, the p-nitrobenzaldehyde derivative of 4 hydrazinosulpholan-3-ol, and the benzaldehyde derivative of N-methyl-N-sulphonyl hydrazine. In general, the hydrazines may be reacted with benzenesulphonyl chloride, and other acyl chlorides, acids, esters, aldehydes, ketones, keto-acids and unsaturated acids.
priorityDate 1959-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415941320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432073477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432256464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID328225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411471813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432219830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154245017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432229796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3611767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419596345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154155575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21507127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425992102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20509051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421015250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154224210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414671567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154229907

Total number of triples: 49.